BasingaPMoreiraJBisoffiZBisigBVan denEJ.Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda. Med Decis Making. 2007;27(1):53–60.
2.
PaukerSGKassirerJP.Therapeutic decision making: a cost-benefit analysis. N Engl J Med. 1975;293(5):229–34.
3.
TuyisengeLNdimubanziCPNdayisabaG. Evaluation of latent class analysis and decision thresholds to guide the diagnosis of pediatric tuberculosis in a Rwandan reference hospital. Pediatr Infect Dis J. 2010;29(2):e11–8.
4.
DiamondGAForresterJSHirschM. Application of conditional probability analysis to the clinical diagnosis of coronary artery disease. J Clin Invest. 1980;65(5):1210–21.
5.
Van den EndeJMugabekaziJMoreiraJ. Effect of applying a treatment threshold in a population. An example of pulmonary tuberculosis in Rwanda. J Eval Clin Pract. 2010;16(3):499–508.
6.
MoreiraJAlarconFBisoffiZ. Tuberculous meningitis: does lowering the treatment threshold result in many more treated patients?Trop Med Int Health. 2008;13(1):68–75.
